Sulfonamides as inhibitors of Bcl-2 family proteins for the treatment of cancer

Details for Australian Patent Application No. 2010294292 (hide)

Owner Novartis AG

Inventors Miller-Moslin, Karen; Toure, BakaryBarry; Visser, Michael Scott; Yusuff, Naeem

Agent Davies Collison Cave

Pub. Number AU-A-2010294292

PCT Pub. Number WO2011/029842

Priority 61/241,251 10.09.09 US

Filing date 8 September 2010

Wipo publication date 17 March 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07C 311/20 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

Event Publications

1 March 2012 PCT application entered the National Phase

  PCT publication WO2011/029842 Priority application(s): WO2011/029842

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010294295-A method for generating a security bilevel image for a banknote

2010294283-Process for preparing Cinacalcet